Seaport Therapeutics, Inc. Common Stock (SPTX) — Long-term Investment Intensity

Latest as of December 2025: 7.1%

Seaport Therapeutics, Inc. Common Stock (SPTX) has a Long-term Investment Intensity of 7.1% as of December 2025. Long-term investments of $17.67 Million represent 7.1% of total assets of $249.01 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Also explore SPTX total asset value for the complete picture of this company's asset base.

LT Investment Intensity

7.1%
LT Investments / Total Assets

Long-term Investments

$17.67 Million
USD

Total Assets

$249.01 Million
USD

Country

USA
NASDAQ

Seaport Therapeutics, Inc. Common Stock Long-term Investment Intensity (2025–2025)

This chart shows how Seaport Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of December 2025, the intensity stands at 7.1%, reflecting long-term investments of $17.67 Million against total assets of $249.01 Million USD. See Seaport Therapeutics, Inc. Common Stock book value and equity for net asset value and shareholders' equity analysis.

Annual Long-term Investment Intensity for Seaport Therapeutics, Inc. Common Stock (2025–2025)

The table below presents the year-by-year Long-term Investment Intensity for Seaport Therapeutics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Seaport Therapeutics, Inc. Common Stock.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 7.1% $17.67 Million $249.01 Million
pp = percentage points